Please login to the form below

Not currently logged in
Email:
Password:

Medicxi

This page shows the latest Medicxi news and features for those working in and with pharma, biotech and healthcare.

Novartis and J&J back latest €400m Medicxi biopharma fund

Novartis and J&J back latest €400m Medicxi biopharma fund

to Medicxi, with European companies growing in stature and offering improved returns on investment for backers. ... to the US, Medicxi’s co-founder Francesco De Rubertis told the Financial Times.

Latest news

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Medicxi appoints former GSK chair Moncef Slaoui Medicxi appoints former GSK chair Moncef Slaoui

    He joins the life science investment firm as a partner. London, UK-based life science investment group Medicxi has appointed former GSK chairman of pharmaceutical R&D, vaccines Dr Moncef Slaoui ... He said: “Having developed a strong relationship with

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
VISFO

A team of strategic decision specialists with over 30+ years in the pharma space, we give you confidence through experience....

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....